1-(5-bromo-1-(phenylsulfonyl)-1H-indol-3-yl)ethanone | 121963-43-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(5-bromo-1-(phenylsulfonyl)-1H-indol-3-yl)ethanone
• 英文别名: 1-[1-(benzenesulfonyl)-5-bromoindol-3-yl]ethanone
• CAS: 121963-43-7
• 化学式: C₁₆H₁₂BrNO₃S
• 分子量: 378.246
• InChiKey: TZPGSYXLOPWQGT-UHFFFAOYSA-N

物化性质

• 熔点：
  161-163 °C(Solvent: Ethanol)
• 沸点：
  553.2±53.0 °C(Predicted)
• 密度：
  1.54±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  64.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(5-bromo-1-(phenylsulfonyl)-1H-indol-3-yl)ethanone 在 sodium tetrahydroborate 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 以81%的产率得到5-bromo-3-ethyl-1-(phenylsulfonyl)indole
  参考文献：
  名称：

  Synthesis of alkyl-substituted N-protected indoles via acylation and reductive deoxygenation

  摘要：

  DOI：

  10.1021/jo00279a023
• 作为产物：
  描述：

  苯磺酰氯 在 aluminum (III) chloride 、 苄基三乙基氯化铵 、 sodium hydroxide 作用下， 以 二氯甲烷 为溶剂， 反应 1.33h， 生成 1-(5-bromo-1-(phenylsulfonyl)-1H-indol-3-yl)ethanone
  参考文献：
  名称：

  Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety

  摘要：

  Thirty-six N-arylsulfonyl-3-substituted indoles were designed and synthesized by combining the N-arylsulfonylindoles with aminoguanidine, semicarbazide, and thiosemicarbazide, respectively. Their antibacterial activities were screened, and cytotoxic activities were evaluated. The results showed that aminoguanidines (6) exhibited much better antibacterial activity than semicarbazides (7) and thiosemicarbazides (8). Most compounds in series 6 showed potent inhibitory activity against the tested bacterial strains, including multidrug-resistant strains, with MIC values in the range of 1.08-23.46 mu M. The cytotoxic activity of the compounds 6c, 6d, 6h, 6j, 6k and 6l was assessed in two human cancer cell lines A590 and SGC7901, and one human normal cell line HEK 293T. The results indicated that compounds selected exhibited excellent activity against the tested cancer cells with IC50 values in the range of 1.51-15.12 mu M suggesting the potential of them as new antibacterial and anticancer agents. What's more, the results of resistance study revealed that resistance of the tested bacteria toward 6d is not easily developed. Molecular docking studies revealed that the aminoguanidine and arylsulfonylindole moieties played a significant role in binding the target site of E. coli FabH-CoA receptor. (C) 2019 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2019.01.038

文献信息

• [EN] N-ARYLSULFONYL-3-SUBSTITUTED INDOLES HAVING SEROTONIN RECEPTOR AFFINITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM<br/>[FR] INDOLES N-ARYLSULFONYL-3-SUBSTITUES PRESENTANT UNE AFFINITE POUR LE RECEPTEUR DE LA SEROTONINE, METHODE DE PREPARATION ET COMPOSITION PHARMACEUTIQUE CONTENANT CES INDOLES
  申请人：SUVEN LIFE SCIENCES LTD

  公开号：WO2004048330A1

  公开（公告）日：2004-06-10

  The present invention relates to novel N-arylsulfonyl-3-substituted indole compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their geometric forms, their N-oxides, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel N-arylsulfonyl-3-substituted indoles of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates, and pharmaceutically acceptable compositions containing them. This invention also relates to the process for preparing compounds of the general formula (I), pharmaceutical compositions containing such compounds and the use of such compounds and compositions in medicine. This invention also relates to the novel intermediates involved therein and process of their preparation.

  本发明涉及新型的N-芳基亚磺酰基-3-取代吲哚化合物、其衍生物、类似物、互变异构体、立体异构体、几何异构体、N-氧化物、多晶型、药物可接受的盐、药物可接受的溶剂化物以及含有它们的药物可接受组合物。本发明特别涉及具有通用公式(I)的新型N-芳基亚磺酰基-3-取代吲哚、其衍生物、类似物、互变异构体、立体异构体、多晶型、药物可接受的盐、药物可接受的溶剂化物以及含有它们的药物可接受组合物。本发明还涉及制备通用公式(I)化合物的过程、含有此类化合物的药物组合物以及此类化合物和组合物在医学中的用途。本发明还涉及其中涉及的新中间体及其制备过程。
• Novel and Simple Methodology for the Synthesis of 3-Acetylindoles and their N-Alkyl Derivatives Using TBAB as Phase Transfer Catalyst
  作者：M. Venkatanarayana、Pramod K. Dubey

  DOI：10.2174/157017811799304395

  日期：2011.11.1

  Using 5% aq. NaOH, a simple method for the transformation of 3-cyanoacetylindoles 2(a-e) into 3- acetylindoles 3 (a-e), in good yields, is reported. Tetrabutylammoniumbromide (TBAB) is found to be an efficient phase transfer catalyst for the synthesis of N-alkyl derivatives 5(a-t) of 3-acetylindoles 3(a-e) giving products in excellent yields. 2 (a-e) were themselves obtained from simple indoles 1 (a-e) by reaction with cyano acetic acid in the presence of propionic anhydride at 100 °C for 5-10 min. Partial hydrolysis of 2 (a-e) under hot acidic conditions yielded the corresponding carboxamides α-(3-indolecarboxoyl)acetamides 4(a-e). Which could be readily transformed into the respective 3(a-e) by refluxing with 5% aq. NaOH for 2-2.5 h.

  报道了一种利用5%氢氧化钠水溶液，将3-氰基乙酰基吲哚2(a-e)高效转化为3-乙酰基吲哚3(a-e)的简便方法。四丁基溴化铵（TBAB）被发现是一种有效的相转移催化剂，用于合成3-乙酰基吲哚3(a-e)的N-烷基衍生物5(a-t)，产率优异。2(a-e)本身是通过吲哚1(a-e)与氰基乙酸在丙酸酐存在下于100°C反应5-10分钟得到的。在热酸性条件下部分水解2(a-e)，得到相应的羧酰胺α-(3-吲哚羧酰基)乙酰胺4(a-e)，这些羧酰胺可以通过与5%氢氧化钠水溶液回流2-2.5小时，容易地转化为相应的3(a-e)。
• [EN] PERFORIN INHIBITING BENZENESULFONAMIDE COMPOUNDS, PREPARATION AND USES THEREOF<br/>[FR] COMPOSÉS DE BENZÈNESULFONAMIDE INHIBITEURS DE LA PERFORINE, LEUR PRÉPARATION ET LEURS UTILISATIONS
  申请人：PETER MACCALLUM CANCER INST

  公开号：WO2014028968A1

  公开（公告）日：2014-02-27

  Compounds of formula (la) and pharmaceutically acceptable salts, solvates, and hydrates thereof and related methods of modulatin perforin activity on a cell: wherein Ring A is selected from a 6-10 membered aryl, 5-6 membered cycloalkyi, 5-6 membered heteroaryl or 5-6 membered heterocyclyl, wherein the heteroaryl and heterocyclyl rings comprise at least one heteroatom selected from N, O or S; and wherein the aryl, cycloalkyi, heteroaryl or heterocyclyl rings are optionally substituted with 1 to 3 substituents selected from halo, nitro, -C1-Cealkyl, -C1-Ceaminoalkyl, -C1-C6hydroxyalkyl, -haloC1-C6alkyl, -C1- C6alkoxyl, -haloC1-C

  公式（la）的化合物及其药学上可接受的盐、溶剂化合物和水合物，以及相关的调节细胞上穿孔素活性的方法：其中环A选自6-10成员芳基、5-6成员环烷基、5-6成员杂芳基或5-6成员杂环烷基，其中杂芳基和杂环烷基环至少包含N、O或S中的一种杂原子；芳基、环烷基、杂芳基或杂环烷基环可以选择地被1至3个取代基取代，所述取代基选自卤素、硝基、-C1-Ce烷基、-C1-Ceamino烷基、-C1-C6羟基烷基、-卤代C1-C6烷基、-C1-C6烷氧基、-卤代C1-C6烷氧基、杂芳基、芳基、羟基、-C(0)Ci-C6烷基、-OC(0)Ci-C6烷基、-CH2OC(O)CrC6烷基、-C(O)OC1,-C6烷基、-NHC(O)C1,-C6烷基、-NHS(O)2C1-C6烷基、-S(O)2C1-C6烷基、-S(O)2NH2和-C(O)NJJ；环B是6-10成员芳基或5-6成员杂芳基，其中至少包含N、O或S中的一种杂原子；芳基或杂芳基可以选择地被一个或多个取代基取代，所述取代基选自-NJJ、-OJ、卤素、C1-C6烷基、卤代C1-C6烷基、C1-C6烷氧基、卤代C1-C6烷氧基和-C(0)NJJ；环C选自5-10成员杂芳基或5-10成员杂环烯，每个环至少包含N、S和O中的一种杂原子；环D是可选择地取代的苯并9-11成员杂环烷基或可选择地取代的苯并9-11成员杂芳基，其中至少包含N或O中的一种杂原子；L是从支链和非支链C1-C4烷基、-S(0)2-NH-、-C(0)-NH-、-NH-C(0)-NH-、-S(0)2-NH-C(0)-NH-、-S(0)2-NH-C(0) -和-CH=CH-中选取的连接物；其中环B和C，以及环C和D，通过各自环上任何可用的C原子之一的C-C键连接在一起；每次出现的J独立地选自H、可选择地取代的C1-C6烷基或可选择地取代的卤代C1-C6烷基。
• An Unusual and Chemoselective Reduction of Ester Grouping in Nsubstituted-3-acetylindoles by Sodium Borohydride
  作者：Muvvala Venkatanarayana、Pramod K. Dubey

  DOI：10.2174/157017812800167402

  日期：2012.3.1

  Treatment of 3-acetylindoles 1(a-e) with ethyl chloroacetate in the presence of K2CO3 and tetrabutylammoniumbromide (TBAB) as phase transfer catalyst in DMF, resulted in the formation of the corresponding N-substituted derivatives, ethyl 2-(3-acetyl-1H-indol-1-yl)acetate 2(a-e) which on reaction with NaBH4 yielded, unexpectedly, ethanol derivatives, 1-(1-(2-hydroxyethyl)-1H-indol-3-yl)ethanone 3(a-e) by the unusual and chemoselective reduction of ester grouping in preference to the acetyl group. Alternative synthesis of the latter was achieved by the treatment of 1(a-e) with 2-chloroethanol under phase transfer catalytic conditions (PTC). 1(a-e), on treatment with benzenesulphonyl chloride, under PTC conditions, yielded the corresponding N-benzenesulphonyl-3- acetylindoles 7(a-e), which on reduction with NaBH4 in methanol afforded the corresponding hydroxy derivatives Nbenzenesulphonyl-( α-hydroxyethyl)indoles 8(a-e). These reactions throw light on the ease of reduction of the 3-acetyl group on indoles with NaBH4.

  用K2CO3和四丁基溴化铵(TBAB)作为相转移催化剂，在DMF中处理3-乙酰吲哚1(a-e)与氯乙酸乙酯，生成相应的N取代衍生物，即乙基2-(3-乙酰-1H-吲哚-1-基)乙酸酯2(a-e)。这些衍生物与NaBH4反应时，意外地产生了乙醇衍生物1-(1-(2-羟乙基)-1H-吲哚-3-基)乙酮3(a-e)，这是因为酯基的还原优先于乙酰基。通过在相转移催化条件(PDC)下用2-氯乙醇处理1(a-e)，也能合成后者。1(a-e)在相转移催化条件下与苯磺酰氯反应，生成相应的N-苯磺酰基-3-乙酰吲哚7(a-e)，这些化合物在甲醇中与NaBH4还原后得到相应的羟基衍生物N-苯磺酰基-(α-羟乙基)吲哚8(a-e)。这些反应说明了使用NaBH4还原吲哚中的3-乙酰基的简单性。
• N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
  申请人：Ramakrishna Satya Nirogi Venkata

  公开号：US20060223890A1

  公开（公告）日：2006-10-05

  N-arylsulfonyl-3-substituted indole compounds, derivatives, analogs, tautomeric forms, stereoisomers, geometric forms, N-oxides, polymorphs and pharmaceutically acceptable salts.

  N-芳基磺酰基-3-取代吲哚化合物，衍生物，类似物，互变异构体，立体异构体，几何异构体，N-氧化物，多晶形式和药学上可接受的盐。